AZZI, ALBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.453
EU - Europa 2.631
AS - Asia 370
AF - Africa 11
OC - Oceania 5
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.436
PL - Polonia 796
IE - Irlanda 453
SE - Svezia 446
IT - Italia 360
UA - Ucraina 203
HK - Hong Kong 163
DE - Germania 119
FI - Finlandia 116
CN - Cina 80
JO - Giordania 67
GB - Regno Unito 59
SG - Singapore 25
FR - Francia 21
TR - Turchia 20
CA - Canada 17
RU - Federazione Russa 15
AT - Austria 14
CH - Svizzera 11
VN - Vietnam 10
BE - Belgio 7
SC - Seychelles 5
NL - Olanda 4
AU - Australia 3
BR - Brasile 3
KR - Corea 3
MU - Mauritius 3
SM - San Marino 3
ES - Italia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
A1 - Anonimo 1
EG - Egitto 1
IN - India 1
SA - Arabia Saudita 1
Totale 7.474
Salva come PNG Salva come JPEG
Città #
Warsaw 796
Fairfield 700
Chandler 513
Dublin 452
Woodbridge 335
Jacksonville 320
Ashburn 308
Cambridge 291
Houston 252
Seattle 251
Wilmington 201
Princeton 125
Ann Arbor 119
Boston 71
Florence 67
Hong Kong 66
Medford 66
Kent 61
Boardman 58
Altamura 48
Lawrence 45
Buffalo 43
San Diego 34
Beijing 33
Milan 31
Shanghai 30
Norwalk 27
Izmir 20
Singapore 17
Wayne 16
Rome 14
Vienna 14
Hillsboro 12
Toronto 12
Andover 10
Saint Petersburg 10
Dong Ket 8
Bari 7
Brussels 7
Falls Church 7
Los Angeles 7
New York 7
Sesto Fiorentino 7
Brescia 6
Frankfurt Am Main 6
Laurel 6
Phoenix 6
London 5
Romano di Lombardia 5
Ancona 4
Bern 4
Ottawa 4
San Giovanni Valdarno 4
Sovicille 4
Verona 4
Caivano 3
Cinisello Balsamo 3
Fucecchio 3
Fuzhou 3
Montegiardino 3
Redwood City 3
Reggio Calabria 3
Reggio Nell'emilia 3
Wettingen 3
Altopascio 2
Barcelona 2
Bologna 2
Carini 2
Cascina 2
Caserta 2
Central 2
Corzano 2
Empoli 2
Horn 2
Leawood 2
Limbiate 2
Melbourne 2
Mola di Bari 2
Naples 2
Negrar 2
Paglieta 2
Parma 2
Pesaro 2
Redmond 2
Rimini 2
Sarno 2
Seoul 2
Skopje 2
Tappahannock 2
Tunis 2
Turin 2
West Jordan 2
Anghiari 1
Atella 1
Auburn Hills 1
Auckland 1
Bauru 1
Birmingham 1
Bremen 1
Castelnuovo Berardenga 1
Totale 5.667
Salva come PNG Salva come JPEG
Nome #
H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support 237
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. 231
Molecular markers of influenza B lineages and clades 219
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 217
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 212
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center 208
Artrite reumatoide e parvovirus B19: osservazioni preliminari 147
Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS) 103
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 102
A real-time reverse transcriptase-polymer chain reaction to evaluate natural history of viral shedding in outpatient children and adolescents with pandemic 2009 influenza A(H1N1). 99
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 97
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 96
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 95
CONFUTAZIONE DI RECENTI IPOTESI ETIOLOGICHE PER LA PITIRIASI ROSEA DI GIBERT. 95
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. 94
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 94
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 87
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products. 84
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 84
BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. 83
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. 83
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 83
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. 82
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 81
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. 81
HA222 polymorphism in Influenza A(H1N1) 2009 isolates from Intensive Care Units and ambulatory patients during three influenza seasons. 80
Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. 79
Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. 79
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients 78
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. 78
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. 77
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 77
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 77
TT virus contaminates first-generation recombinant factor VIII concentrates. 74
No association between human parvovirus B19 infection and Sjogren's syndrome. 74
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 73
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis 73
A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus. 72
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 71
Polyomavirus BK-specific immunity after kidney transplantation. 69
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. 69
Parvovirus B19 and systemic sclerosis. 68
Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children. 68
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. 68
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction 67
The transfusion-associated transmission of parvovirus B19. 67
Human parvovirus B19 infection in bone marrow transplantation patients 66
High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. 66
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. 66
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. 65
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. 65
Parvovirus B19 infection in cultured skin fibroblasts from systemic sclerosis patients: a comment on the article of Ray et al. 63
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 62
Detection of B19 parvovirus infections by dot-blot hybridization assay using a digoxigenin-labelled probe 62
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients 62
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 61
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 60
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 60
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. 60
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 59
INTRAUTERINE PARVOVIRUS B19 INFECTION: EARLY PRENATAL DIAGNOSIS IS POSSIBLE. 59
Unusual incidence of aplastic Anaemia due to B19 parvovirus infection in renal transplant recipients 59
Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. 56
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 56
Polymerase chain reaction for synthesis of digoxigenin-labelled DNA probe: application to parvovirus B19 and to polyomavirus BK 56
Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera 55
Indagine epidemiologica sull'infezione da parvovirus B19 in diverse categorie 55
Use of denaturing gradient gel electrophoresis for human polyomavirus JC sequence analysis. 54
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 54
Cryptococcose chez le chien: deux cas cliniques. 53
Cryptococcose disséminée chez le chat. 52
Parvovirus B19 and systemic sclerosis 51
NO ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND SJÖGREN¿S SINDROME. 49
Human parvovirus B19 infection within a family and risk for pregnant women 49
Letter to Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated Factor VIII concentrate: the role of human B19 parvovirus 49
Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. 48
BKV e HPV nel sarcoma di Kaposi (KS) AIDS correlate 46
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 44
Parvovirus B19 infection of bone marrow in systemic sclerosis patients 43
aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia 43
Sorveglianza delle infezioni fungine nelle leucemie acute. 43
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 43
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrate 41
Inchiesta sulla diffusione della criptococcosi nei portatori di HIV in Italia 40
Cryptococcus infection in immunodepressed subjects 39
First-generation recombinant factor VIII concentratesare free from viral contaminations? 38
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients 38
BK and JC viruses 38
Hemorrahagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia 37
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. 35
Cytopenia caused by parvovirus in adult ALL patient 35
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 34
Development of a Quantitative Competitive Polymerase Chain Reaction for Human Polyomavirus BK 34
Ricerca del Poliomavirus JC in pazienti con malattie reumatiche sottoposti ad un trattamento a lungo termine con infliximab. 29
Persistent parvovirus B19 infection within a family and risk for pregnant women 27
New influenza virus type A (H1N1), isolated in Florence. 27
Rosolia o V malattia? la risposta nella diagnosi di laboratorio 27
Presence of TT virus DNA in bone marrow cells from hematologic patients. 26
Development of multiplex RT-PCR specific for the eight genomic segments of avian influenza A H7N3 viruses. 26
Sonda marcata con digossigenina per la ricerca di BKV 26
Totale 7.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.640 150 132 44 147 171 202 173 214 160 88 132 27
2020/2021982 107 63 78 87 36 148 29 82 80 134 61 77
2021/2022616 18 68 15 21 33 31 15 33 43 27 106 206
2022/20231.907 223 226 89 140 163 399 265 100 213 16 51 22
2023/2024617 37 84 123 23 34 32 24 94 9 33 83 41
2024/202538 38 0 0 0 0 0 0 0 0 0 0 0
Totale 7.536